The Singapore Medical Device Venture Showcase, held on 29 June 2026, marked a significant step in enhancing Singapore’s role as a hub for medical technology ventures. The event saw the launch of Santé Accel Singapore, a new healthcare venture-building platform designed to support the growth of MedTech, Biotech, and HealthTech startups. This initiative, established by Santé Ventures in partnership with SG Growth Capital, aims to provide mentorship and access to global healthcare networks.
The showcase, co-organised by MedTech Catapult, the Agency for Science, Technology and Research (A*STAR), Enterprise Singapore, and the Singapore Economic Development Board, brought together global investors and innovators. It focused on translating innovation into clinically validated and commercially viable healthcare solutions, particularly through AI-enabled technologies.
Dr Tan See Leng, Singapore’s Minister-in-charge of Energy and Science & Technology, attended as Guest of Honour. The event highlighted the potential of over 25 MedTech startups, showcasing innovations in medical imaging, minimally invasive technologies, and AI-enabled care. These startups are advancing towards real-world applications, with some reaching first-in-human trials.
Industry leaders shared insights on navigating the journey from clinical development to global expansion. Irene Cheong of A*STAR emphasised Singapore’s strength in supporting MedTech innovation, whilst Wong Zeng Yi of EnterpriseSG highlighted the country’s robust R&D capabilities. Goh Wan Yee of EDB noted the sector’s growth, with over S$20 billion in high-value products manufactured for the global market in 2025.
The launch of Santé Accel Singapore underscores the continued confidence in Singapore’s healthcare ecosystem, reinforcing its position as a hub for healthcare innovation and venture creation.
